Ftse Mib
34.188,15
-0,16%
DAX
18.521,53
0,45%
S&P 500
5.187,70
0,13%
NASDAQ
16.332,56
-0,10%
Bitcoin
62.417,76
0,13%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Achillion Pharmaceuticals Inc (ACHN) Achillion Pharmaceuticals Inc (ACHN) Notizie

ACHN

Achillion Pharmaceuticals (ACHN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACHN
DataOraFonteTitoloSimboloCompagnia
14/02/202022:55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACHNAchillion Pharmaceuticals Inc
14/02/202019:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/02/202012:11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ACHNAchillion Pharmaceuticals Inc
03/02/202012:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
19/12/201915:24GlobeNewswire Inc.Achillion Shareholders Approve Agreement to be Acquired by AlexionNASDAQ:ACHNAchillion Pharmaceuticals Inc
09/12/201916:00GlobeNewswire Inc.Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who...NASDAQ:ACHNAchillion Pharmaceuticals Inc
22/11/201916:42PR Newswire (US)Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...NASDAQ:ACHNAchillion Pharmaceuticals Inc
19/11/201913:30GlobeNewswire Inc.European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients...NASDAQ:ACHNAchillion Pharmaceuticals Inc
11/11/201913:30GlobeNewswire Inc.Achillion Announces Clearance of Investigational New Drug Application for ACH-5228NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201922:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201922:18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201922:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACHNAchillion Pharmaceuticals Inc
07/11/201913:30GlobeNewswire Inc.Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:ACHNAchillion Pharmaceuticals Inc
06/11/201915:07GlobeNewswire Inc.Achillion Announces Data Presentations at the 61st American Society of Hematology Annual MeetingNASDAQ:ACHNAchillion Pharmaceuticals Inc
05/11/201923:07Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
01/11/201921:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
18/10/201923:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHNAchillion Pharmaceuticals Inc
18/10/201922:50PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201916:44PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in it...NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201914:50PR Newswire (US)Achillion (ACHN) Alert: Johnson Fistel Investigates Proposed Sale of Achillion Pharmaceuticals; Are Shareholders Getting a Fa...NASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201914:28Dow Jones NewsAchillion Pharmaceuticals Shares Up 84% on Buyout DealNASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201913:24Dow Jones NewsAlexion Pharmaceuticals Buys Achillion Pharma for $930 MillionNASDAQ:ACHNAchillion Pharmaceuticals Inc
16/10/201912:30Business WireAlexion to Acquire AchillionNASDAQ:ACHNAchillion Pharmaceuticals Inc
26/09/201914:32GlobeNewswire Inc.Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:ACHNAchillion Pharmaceuticals Inc
25/09/201913:00GlobeNewswire Inc.Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinur...NASDAQ:ACHNAchillion Pharmaceuticals Inc
29/08/201923:00GlobeNewswire Inc.Achillion to Present at the Baird 2019 Global Healthcare ConferenceNASDAQ:ACHNAchillion Pharmaceuticals Inc
08/08/201913:30GlobeNewswire Inc.Achillion Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:ACHNAchillion Pharmaceuticals Inc
22/07/201913:00GlobeNewswire Inc.Achillion’s ACH-5228 Achieves Positive Results in Phase 1 Multiple Ascending Dose Study in Healthy VolunteersNASDAQ:ACHNAchillion Pharmaceuticals Inc
13/06/201913:00GlobeNewswire Inc.Achillion to Present at the JMP Securities Life Sciences ConferenceNASDAQ:ACHNAchillion Pharmaceuticals Inc
10/06/201913:00GlobeNewswire Inc.Achillion Announces Upcoming Scientific Presentation at the 24th Congress of the European Hematology AssociationNASDAQ:ACHNAchillion Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ACHN

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BAMI
Banco BPM
BIT
ENEL
Enel
BIT
CPR
Davide Campari
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
IRE
Iren
BIT
FBK
Finecobank
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
MAIRE
Maire Tecnimont
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network